Silence Therapeutics SLN
NASDAQ SLN
$14.59 -0.20 (-1.35%)
As of: Sep 4, 2026 · 3:59 PM EDT

Silence Therapeutics (SLN) Property, Plant & Equipment (Net) (2018 - 2026)

Analysis

Silence Therapeutics (SLN) Property, Plant & Equipment (Net) (2018 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 1.67 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 5.46 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 1.96 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 2.06 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 34.61 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 1.64 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 554.14 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 107.22 Mn
10 Silence Therapeutics 690.60 Mn 618.50 Mn - 1.33 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.33 Mn
Mar 31, 2026 1.40 Mn
Dec 31, 2025 1.58 Mn
Sep 30, 2025 1.66 Mn
Jun 30, 2025 1.78 Mn
Mar 31, 2025 1.69 Mn
Dec 31, 2024 1.82 Mn
Dec 31, 2023 15.89 Mn
Dec 31, 2022 12.68 Mn
Dec 31, 2021 13.29 Mn
Dec 31, 2020 12.64 Mn
Dec 31, 2019 11.07 Mn
Dec 31, 2018 12.08 Mn